Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenghong Liang

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Endocrinology|July 4, 2025
Association between glycemia risk index and carotid intima-media thickness in type 2 diabetesLingyun Zhao, Hongyan Heng, Qinyuan Xie, et al.
Frontiers in Cellular and Infection Microbiology|March 27, 2024
Altered ocular surface microbiota in obesity: a case-control studyChenghong Liang, Limin Wang, Xiudan Wang, et al.
Biomaterials|September 5, 2024
Biomimetic nanoplatform with microbiome modulation and antioxidant functions ameliorating insulin resistance and pancreatic β-cell dysfunction for T2DM managementXiudan Wang, Rui Tian, Chenghong Liang, et al.
Frontiers in Endocrinology|October 23, 2023
Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitusLimin Wang, Chenghong Liang, Xiaojian Song, et al.
Food Research International (Ottawa, Ont.)|May 12, 2026
Timing matters in type 2 diabetes: Early high-Fiber nutrition enhances glycemic control and reshapes gut microbiotaLimin Wang, Chenghong Liang, Jiawei Yu, et al.
Microbiome|December 30, 2025
Modulation of gut microbiota in Graves' orbitopathy: Prevotella dominance and atorvastatin's impactDanyu Wang, Yaonan Chen, Junpeng Yang, et al.
Frontiers in Cellular and Infection Microbiology|September 18, 2025
Gut microbiota and its metabolites promote painful diabetic peripheral neuropathy complicated with cognitive dysfunction in miceJunpeng Yang, Xin Lv, Ya Xu, et al.
Mbio|May 31, 2024
Guild-level signature of gut microbiome for diabetic kidney diseaseShasha Tang, Guojun Wu, Yalei Liu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Endocrinology|July 4, 2025
Association between glycemia risk index and carotid intima-media thickness in type 2 diabetesLingyun Zhao, Hongyan Heng, Qinyuan Xie, et al.
Frontiers in Cellular and Infection Microbiology|March 27, 2024
Altered ocular surface microbiota in obesity: a case-control studyChenghong Liang, Limin Wang, Xiudan Wang, et al.
Biomaterials|September 5, 2024
Biomimetic nanoplatform with microbiome modulation and antioxidant functions ameliorating insulin resistance and pancreatic β-cell dysfunction for T2DM managementXiudan Wang, Rui Tian, Chenghong Liang, et al.
Frontiers in Endocrinology|October 23, 2023
Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitusLimin Wang, Chenghong Liang, Xiaojian Song, et al.
Food Research International (Ottawa, Ont.)|May 12, 2026
Timing matters in type 2 diabetes: Early high-Fiber nutrition enhances glycemic control and reshapes gut microbiotaLimin Wang, Chenghong Liang, Jiawei Yu, et al.
Microbiome|December 30, 2025
Modulation of gut microbiota in Graves' orbitopathy: Prevotella dominance and atorvastatin's impactDanyu Wang, Yaonan Chen, Junpeng Yang, et al.
Frontiers in Cellular and Infection Microbiology|September 18, 2025
Gut microbiota and its metabolites promote painful diabetic peripheral neuropathy complicated with cognitive dysfunction in miceJunpeng Yang, Xin Lv, Ya Xu, et al.
Mbio|May 31, 2024
Guild-level signature of gut microbiome for diabetic kidney diseaseShasha Tang, Guojun Wu, Yalei Liu, et al.
Pageof 1